Search research articles
Contact Us
Filters
Showing results (31-40 of 82) with videos related to
Page
of 9
Sort By:
Clinical Immunology (Orlando, Fla.)
|
January 31, 2025
Effect of repurposed metabolic drugs on human macrophage polarization and antitumoral activity
Ana Vizcaino-Castro, Shipeng Chen, Baukje Nynke Hoogeboom, et al.
Expert Review of Vaccines
|
June 23, 2011
Vaccine-based clinical trials in ovarian cancer
Ninke Leffers, Toos Daemen, H Marike Boezen, et al.
Virus Research
|
January 2, 2019
The cellular stress response in hepatitis C virus infection: A balancing act to promote viral persistence and host cell survival
W Alfredo Ríos-Ocampo, María-Cristina Navas, Klaas Nico Faber, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
February 2, 2006
Recombinant alphaviruses as vectors for anti-tumour and anti-microbial immunotherapy
Annelies Riezebos-Brilman, Arjan de Mare, Laura Bungener, et al.
Vaccine
|
January 18, 2005
Virosome-mediated delivery of protein antigens in vivo: efficient induction of class I MHC-restricted cytotoxic T lymphocyte activity
Laura Bungener, Anke Huckriede, Arjan de Mare, et al.
Antiviral Therapy
|
November 13, 2004
Superior therapeutic efficacy of alphavirus-mediated immunization against human papilloma virus type 16 antigens in a murine tumour model: effects of the route of immunization
Toos Daemen, Annelies Riezebos-Brilman, Joke Regts, et al.
Vaccine
|
July 20, 2005
The virosome concept for influenza vaccines
Anke Huckriede, Laura Bungener, Toon Stegmann, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
December 28, 2013
Alphavirus-based vaccines encoding nonstructural proteins of hepatitis C virus induce robust and protective T-cell responses
Peng Peng Ip, Annemarie Boerma, Joke Regts, et al.
Vaccine
|
January 28, 2003
Influenza virosomes: combining optimal presentation of hemagglutinin with immunopotentiating activity
Anke Huckriede, Laura Bungener, Wouter ter Veer, et al.
Vaccine
|
March 9, 2004
Induction of cytotoxic T lymphocyte activity by immunization with recombinant Semliki Forest virus: indications for cross-priming
Anke Huckriede, Laura Bungener, Marijke Holtrop, et al.
Page
of 9
Search research articles
Search
Showing results (31-40 of 82) with videos related to
Sort By:
Page
of 9
Clinical Immunology (Orlando, Fla.)
|
January 31, 2025
Effect of repurposed metabolic drugs on human macrophage polarization and antitumoral activity
Ana Vizcaino-Castro, Shipeng Chen, Baukje Nynke Hoogeboom, et al.
Expert Review of Vaccines
|
June 23, 2011
Vaccine-based clinical trials in ovarian cancer
Ninke Leffers, Toos Daemen, H Marike Boezen, et al.
Virus Research
|
January 2, 2019
The cellular stress response in hepatitis C virus infection: A balancing act to promote viral persistence and host cell survival
W Alfredo Ríos-Ocampo, María-Cristina Navas, Klaas Nico Faber, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
February 2, 2006
Recombinant alphaviruses as vectors for anti-tumour and anti-microbial immunotherapy
Annelies Riezebos-Brilman, Arjan de Mare, Laura Bungener, et al.
Vaccine
|
January 18, 2005
Virosome-mediated delivery of protein antigens in vivo: efficient induction of class I MHC-restricted cytotoxic T lymphocyte activity
Laura Bungener, Anke Huckriede, Arjan de Mare, et al.
Antiviral Therapy
|
November 13, 2004
Superior therapeutic efficacy of alphavirus-mediated immunization against human papilloma virus type 16 antigens in a murine tumour model: effects of the route of immunization
Toos Daemen, Annelies Riezebos-Brilman, Joke Regts, et al.
Vaccine
|
July 20, 2005
The virosome concept for influenza vaccines
Anke Huckriede, Laura Bungener, Toon Stegmann, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
December 28, 2013
Alphavirus-based vaccines encoding nonstructural proteins of hepatitis C virus induce robust and protective T-cell responses
Peng Peng Ip, Annemarie Boerma, Joke Regts, et al.
Vaccine
|
January 28, 2003
Influenza virosomes: combining optimal presentation of hemagglutinin with immunopotentiating activity
Anke Huckriede, Laura Bungener, Wouter ter Veer, et al.
Vaccine
|
March 9, 2004
Induction of cytotoxic T lymphocyte activity by immunization with recombinant Semliki Forest virus: indications for cross-priming
Anke Huckriede, Laura Bungener, Marijke Holtrop, et al.
Page
of 9